Radiance Therapeutics Overview
- Year Founded
-
2018
- Status
-
Out of Business
- Employees
-
4
- Latest Deal Type
-
Out of Business
Radiance Therapeutics General Information
Description
Developer of a beta ophthalmic applicator designed to offer an anti-metabolite therapy for glaucoma drainage surgery. The company's applicator downregulates fibroblasts that cause scar tissue, keeping the channel open and maintaining reduced intraocular pressure, which improves glaucoma surgery outcomes, enabling patients to have access to clinically demonstrated novel anti-metabolite therapy for glaucoma drainage surgery.
Contact Information
Website
www.radiancetherapeutics.comCorporate Office
- 7440 North Oracle Road
- Building 1
- Tucson, AZ 85704
- United States
Corporate Office
- 7440 North Oracle Road
- Building 1
- Tucson, AZ 85704
- United States
Radiance Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Out of Business | 28-Oct-2026 | Completed | Out of Business | |||
| 5. Later Stage VC | 28-Jun-2023 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 28-Dec-2020 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 30-Aug-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 09-Jan-2019 | $4.58M | $5.58M | Completed | Generating Revenue | |
| 1. Seed Round | 31-May-2018 | $1M | $1M | Completed | Generating Revenue |
Radiance Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Radiance Therapeutics Patents
Radiance Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4262974-A1 | Radionuclide brachytherapy source systems for application of beta radiation | Pending | 17-Dec-2020 | ||
| EP-4262974-A4 | Radionuclide brachytherapy source systems for application of beta radiation | Pending | 17-Dec-2020 | ||
| WO-2021142298-A1 | Methods, systems, and compositions for maintaining functioning drainage blebs | Inactive | 08-Jan-2020 | ||
| WO-2021142255-A1 | Methods, systems, and compositions for maintaining functioning drainage blebs associated with foreign bodies | Inactive | 08-Jan-2020 | ||
| WO-2022133275-A1 | Radionuclide brachytherapy source systems for application of beta radiation | Inactive | 08-Jan-2020 | A61N5/1028 |
Radiance Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Radiance Therapeutics FAQs
-
When was Radiance Therapeutics founded?
Radiance Therapeutics was founded in 2018.
-
Where is Radiance Therapeutics headquartered?
Radiance Therapeutics is headquartered in Tucson, AZ.
-
What is the size of Radiance Therapeutics?
Radiance Therapeutics has 4 total employees.
-
What industry is Radiance Therapeutics in?
Radiance Therapeutics’s primary industry is Surgical Devices.
-
Is Radiance Therapeutics a private or public company?
Radiance Therapeutics is a Private company.
-
What is Radiance Therapeutics’s current revenue?
The current revenue for Radiance Therapeutics is .
-
How much funding has Radiance Therapeutics raised over time?
Radiance Therapeutics has raised $16.3M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
